Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and chlorpromazine

olmesartan has been researched along with chlorpromazine in 5 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(chlorpromazine)		Trials
(chlorpromazine)		Recent Studies (post-2010) (chlorpromazine)
84118555417,497777739

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)chlorpromazine (IC50)
Adenylate cyclase type 1 Rattus norvegicus (Norway rat)1.3
Spike glycoproteinBetacoronavirus England 19.51
Replicase polyprotein 1abBetacoronavirus England 19.51
Solute carrier family 22 member 1 Homo sapiens (human)4.3
Transmembrane protease serine 2Homo sapiens (human)9.51
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)0.85
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)3.4
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.0052
Potassium channel subfamily K member 2Homo sapiens (human)2.7
Tyrosine-protein kinase FynHomo sapiens (human)8.68
Procathepsin LHomo sapiens (human)9.51
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.019
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.652
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.149
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.025
Alpha-2A adrenergic receptorHomo sapiens (human)0.352
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus9.51
Replicase polyprotein 1abHuman coronavirus 229E9.51
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus9.51
Calmodulin-1Homo sapiens (human)7.63
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 29.51
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.083
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)5.8275
D(2) dopamine receptorHomo sapiens (human)0.0142
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.031
Alpha-2B adrenergic receptorHomo sapiens (human)0.026
Alpha-2C adrenergic receptorHomo sapiens (human)0.374
DRattus norvegicus (Norway rat)0.1414
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0416
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)4.685
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)1.4791
D(2) dopamine receptorBos taurus (cattle)0.5328
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.206
D(1A) dopamine receptorHomo sapiens (human)0.225
D(4) dopamine receptorHomo sapiens (human)1.365
Adenylate cyclase type 3Rattus norvegicus (Norway rat)1.3
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)1.4791
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)1.4791
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.031
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.019
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)1.4791
Histamine H2 receptorHomo sapiens (human)2.626
Alpha-1D adrenergic receptorHomo sapiens (human)0.004
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0416
Adenylate cyclase type 2Rattus norvegicus (Norway rat)1.3
Adenylate cyclase type 4Rattus norvegicus (Norway rat)1.3
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0036
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0052
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)4.685
Trypanothione reductaseTrypanosoma cruzi5.8
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0416
Sodium-dependent serotonin transporterHomo sapiens (human)0.0795
Melanocortin receptor 5Homo sapiens (human)7.617
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C4.5
Histamine H1 receptorHomo sapiens (human)0.0145
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.3
D(3) dopamine receptorHomo sapiens (human)0.012
Sodium channel protein type 1 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 4 subunit alphaHomo sapiens (human)4.3
Adenylate cyclase type 8Rattus norvegicus (Norway rat)1.3
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.126
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.031
5-hydroxytryptamine receptor 6Homo sapiens (human)0.057
Spike glycoproteinSevere acute respiratory syndrome-related coronavirus9.51
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0365
Calmodulin Bos taurus (cattle)2.5
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)1.3
Sodium channel protein type 7 subunit alphaHomo sapiens (human)4.3
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)3.4
Sodium-dependent dopamine transporter Homo sapiens (human)2.643
Adenylate cyclase type 6Rattus norvegicus (Norway rat)1.3
Adenylate cyclase type 5Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.85
Aldehyde oxidaseHomo sapiens (human)0.57
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.9602
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)0.85
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)3.4
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)3.4
Sodium channel protein type 5 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)0.85
Sodium channel protein type 9 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)1.3
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)5.8275
Adenylyl cyclase 7 Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)1.3
DBos taurus (cattle)0.646
Sodium channel protein type 2 subunit alphaHomo sapiens (human)4.3
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.451
Angiotensin-converting enzyme 2 Homo sapiens (human)9.51
Sodium channel protein type 3 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)1.3
Sodium channel protein type 11 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 8 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 10 subunit alphaHomo sapiens (human)4.3

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

5 other study(ies) available for olmesartan and chlorpromazine

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023